Table III.
Association between SOX2, Oct4, KLF4, c-Myc and brachyury positive expression ratio and clinicopathological factors in 108 oral squamous cell carcinoma patients.
SOX2 expression, n | Oct4 expression, n | KLF4 expression, n | c-Myc expression, n | Brachyury expression, n | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinicopathological parameter | Cases, n | Low | High | P-value | Low | High | P-value | Low | High | P-value | Low | High | P-value | Low | High | P-value |
Age, years | 0.56 | 0.846 | 0.846 | 0.332 | 0.560 | |||||||||||
<65 | 61 | 29 | 32 | 31 | 30 | 31 | 30 | 33 | 28 | 32 | 29 | |||||
≥65 | 47 | 25 | 22 | 23 | 24 | 23 | 24 | 21 | 26 | 22 | 25 | |||||
Gender | 0.317 | 0.161 | 0.317 | 0.548 | 0.071 | |||||||||||
Male | 69 | 32 | 37 | 31 | 38 | 32 | 37 | 33 | 36 | 30 | 39 | |||||
Female | 39 | 22 | 17 | 23 | 16 | 22 | 17 | 21 | 18 | 24 | 15 | |||||
Clinical stage | 0.550 | 0.048a | 0.028a | 0.845 | 0.420 | |||||||||||
T1 | 18 | 11 | 7 | 13 | 5 | 12 | 6 | 9 | 9 | 11 | 7 | |||||
T2 | 46 | 24 | 22 | 22 | 24 | 27 | 19 | 25 | 21 | 25 | 21 | |||||
T3 | 21 | 10 | 1 | 6 | 15 | 9 | 12 | 9 | 12 | 8 | 13 | |||||
T4 | 23 | 9 | 14 | 13 | 10 | 6 | 17 | 11 | 12 | 10 | 13 | |||||
Primary tumor site | 0.030a | 0.465 | 0.329 | 0.091 | 0.045a | |||||||||||
Buccal mucosa | 8 | 6 | 2 | 4 | 4 | 6 | 2 | 6 | 2 | 5 | 3 | |||||
Upper gingiva | 12 | 8 | 4 | 5 | 7 | 6 | 6 | 5 | 7 | 8 | 4 | |||||
Lower gingiva | 22 | 9 | 13 | 11 | 11 | 8 | 14 | 12 | 10 | 10 | 12 | |||||
Tongue | 55 | 29 | 26 | 30 | 25 | 28 | 27 | 29 | 26 | 29 | 26 | |||||
Oral floor | 10 | 1 | 9 | 3 | 7 | 6 | 4 | 1 | 9 | 2 | 8 | |||||
Palate | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | |||||
Lymph node metastasis | 1.000 | 0.046a | 0.425 | 0.111 | 0.425 | |||||||||||
Positive | 40 | 20 | 20 | 15 | 25 | 18 | 22 | 16 | 24 | 18 | 22 | |||||
Negative | 68 | 34 | 34 | 39 | 29 | 36 | 32 | 38 | 30 | 36 | 32 | |||||
Distant metastasis | 0.016a | 0.244 | 0.081 | 0.500 | 0.081 | |||||||||||
Positive | 9 | 1 | 8 | 3 | 6 | 2 | 7 | 4 | 5 | 2 | 7 | |||||
Negative | 99 | 53 | 46 | 51 | 48 | 52 | 47 | 50 | 49 | 52 | 47 | |||||
Tumor differentiation | 0.254 | 0.012a | 0.820 | 0.110 | 0.110 | |||||||||||
Well | 83 | 44 | 39 | 47 | 36 | 42 | 41 | 45 | 38 | 45 | 38 | |||||
Moderate | 25 | 10 | 15 | 7 | 18 | 12 | 13 | 9 | 16 | 9 | 16 | |||||
Poor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Anneroth score | 0.005a | 0.019a | 0.003a | 0.019a | 0.010a | |||||||||||
1 | 7 | 3 | 4 | 6 | 1 | 5 | 2 | 4 | 3 | 5 | 2 | |||||
2 | 14 | 12 | 2 | 6 | 8 | 9 | 5 | 10 | 4 | 10 | 4 | |||||
3 | 54 | 30 | 24 | 31 | 23 | 31 | 23 | 29 | 25 | 27 | 27 | |||||
4 | 33 | 9 | 24 | 11 | 22 | 9 | 24 | 11 | 22 | 12 | 21 |
Significant. SOX2, sex determining region Y-box 2; Oct4, octamer-binding transcription factor 4; c-Myc, avian myelocytomatosis viral oncogene homolog; KLF4, Krüppel-like factor 4.